Fennec Pharmaceuticals Inc.Fennec Pharmaceuticals Inc.Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

No trades
See on Supercharts
Market capitalization
‪284.44 M‬USD
−0.61USD
‪−16.34 M‬USD
‪21.64 M‬USD
‪22.37 M‬
Beta (1Y)
0.51

About Fennec Pharmaceuticals Inc.

CEO
Rostislav C. Raykov
Headquarters
Durham
Employees (FY)
29
Founded
1996
ISIN
CA31447P1009
FIGI
BBG000DTH814
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FENC is 10.33 USD — it has decreased by 1.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fennec Pharmaceuticals Inc. stocks are traded under the ticker FENC.
Fennec Pharmaceuticals Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Fennec Pharmaceuticals Inc. has a max estimate of 20.00 USD and a min estimate of 16.00 USD.
FENC earnings for the last quarter are −0.07 USD whereas the estimation was −0.12 USD which accounts for 41.67% surprise. Estimated earnings for the next quarter are −0.02 USD. See more details about Fennec Pharmaceuticals Inc. earnings.
Fennec Pharmaceuticals Inc. revenue for the last quarter amounts to ‪6.50 M‬ USD despite the estimated figure of ‪5.33 M‬ USD. In the next quarter revenue is expected to reach ‪8.66 M‬ USD.
Yes, you can track Fennec Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, FENC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fennec Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
FENC reached its all-time high on Apr 9, 2018 with the price of 14.99 USD, and its all-time low was 0.04 USD and was reached on Mar 3, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 29.00 employees. See our rating of the largest employees — is Fennec Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fennec Pharmaceuticals Inc. EBITDA is ‪−13.00 M‬ USD, and current EBITDA margin is −60.09%. See more stats in Fennec Pharmaceuticals Inc. financial statements.